PATENT CLAIM ANALYSIS

Application Number: 16040005
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "568000"]

Abstract:
Methods for treating central nervous system (CNS) disorders or attenuating pain with a lithium benzoate compound.

Claim (Index 18):
The method of  claim 1 , wherein the lithium benzoate compound is formulated into a composition, which is a pharmaceutical composition, a medical food, or a health food.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 95.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15655683', '15335027', '15506941', '15834428', '13096423']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7790037119545177
- 35 USC 102 Novelty (BERT): 0.5170008168524325
- Combined Prediction Score: 0.7528034224443091
- Mean Citation Score: 242.38464400000004
- Max Citation Score: 313.29074
- Similarity Product: 246.76972227891684

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test